• AAPL 184.09
  • TSLA 181.3625
  • AMZN 186.28
  • MSFT 406.58
  • INTC 30.865
  • EURUSD 1.0769
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. SA /
  3. A1SN34.SA

Ascendis Pharma A/S (A1SN34 SA) stock market data APIs

R$48.42 0(0%) as of May 2, 2024

Ascendis Pharma A/S Financial Data Overview

48.42
48.42
-
48.42
48.42
27.62-52.9
41 518 M
56 614 K
267 M
0.51
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'A1SN34',
Type: 'Common Stock',
Name: 'Ascendis Pharma A/S',
Exchange: 'SA',
CurrencyCode: 'BRL',
CurrencyName: 'Brazilian real',
CurrencySymbol: 'R$',
CountryName: 'Brazil',
CountryISO: 'BR',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Ascendis Pharma A/S Fundamental Data is available in our Financial Data APIs

  • Net Revenue 267 M
  • EBITDA -448 988 000
  • Earnings Per Share -47.63
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Ascendis Pharma A/S Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Ascendis Pharma A/S End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ascendis Pharma A/S latest news via APIs

Ascendis Pharma Reports First Quarter 2024 Financial Results

Ascendis Pharma — Rollout of YORVIPATH® initiated in Germany and Austria, with an estimated 55 doctors writing prescriptions and ~100 patients receiving commercial product as of March 31 — Tra...

Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024

Ascendis Pharma COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2024 financial results and provide a business u...
Do you have any questions?
support@eodhistoricaldata.com